US FDA approves Roivant-Priovant's skin and muscle disease drug - Reuters
US FDA approves Roivant-Priovant's skin and muscle disease drug Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQTUc2eVR1WE9TcDg4dEExTjhvcXRBenlRM3lLZUlaS19BUU1OZWk0dVVGWWUzSk5nUWtBYXI5bUNTd3R2UU5yWTN2bS1oaGZ6ZlczU3c3aGhGTFFCbFVDcFdmNWwtbkRLU0ZRaTc1T25TQUpkVEdxRWFTLVYxVENZbmtIZU9mSTZ0VzFaUy1iLW1jeGd1M2hPeVJkT3ZweGFzOHpLT2tkVG1qRlV3THFKVQ?oc=5" target="_blank">US FDA approves Roivant-Priovant's skin and muscle disease drug</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Teva wins FDA approval for monthly schizophrenia injection Weltruza - Reuters
Teva wins FDA approval for monthly schizophrenia injection Weltruza Reuters
October 9, 2026 at 11:47 AMAI-based drug developer Basecamp valued at $800 million after $140 million funding round - Reuters
AI-based drug developer Basecamp valued at $800 million after $140 million funding round Reuters
September 23, 2026 at 01:08 PMUS FDA approves Lilly's breast cancer drug combo - Reuters
US FDA approves Lilly's breast cancer drug combo Reuters
September 18, 2026 at 07:17 PMEXCLUSIVE: Anthropic quietly sets up biology lab as it ramps AI drug program - Reuters
EXCLUSIVE: Anthropic quietly sets up biology lab as it ramps AI drug program Reuters
September 18, 2026 at 10:55 AMDrugmakers prepare for next phase of space pharmaceuticals as ISS retirement nears - reuters.com
Drugmakers prepare for next phase of space pharmaceuticals as ISS retirement nears reuters.com
September 17, 2026 at 03:36 PMScholar Rock gets first FDA nod for rare muscle-wasting disease - Reuters
Scholar Rock gets first FDA nod for rare muscle-wasting disease Reuters
September 11, 2026 at 10:59 PM